chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Suspected vaccination failure; Me too have them now; Excruciating pain; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine. Additional details were provided as follows: The age group was not reported but was captured as an adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. The patient also experienced excruciating pain. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided. This case had been linked with case US2021AMR093253, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR093253:Same reporter.
2wks after vaccine started with weakness and pain to bilateral lower extremities and numbness to hands and feet. on 1/11/17 reported increased falls, increased numbness and weakness to extremities. 1/17/17 was seen in ER and diagnosed with Guillain Barre Syndrome then transferred to hospital were treated with Gammaglobulin q6hrs then discharged home 1/24/17 with home PT/OT.
He arrived to the ER after being found at home limp, cyanotic (possibly) and cold the day after receiving his vaccines. He had a fever Tm 101.3 sometime prior to arriving at ER - He was transported from home via ambulance and was stable on arrival to ER.
Fully vaccinated with Three doses of Pfizer. Tested positive for COVID 19 on02/04/2022. Admitted to hospital on 02/04/2022. Expired on 02/08/2022 while still hospitalized.
On December 27th I began to have uticaria on my chest, back, legs and neck that respond to oral diphenhydramine but return after 6-8 hours. This is ongoing for three days so far.
This spontaneous report as received from a pharmacist refers to patients of unknown age. It was reported that MMR II (lot # and expiration date unspecified) had been improperly stored at 47-52F for almost entire month of September at one of the clinics and some doses might have been administered to patients. Specific number of patients was unknown. It was unspecified whether the patients sought for medical attention. The outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
No adverse effects noticed.  Patient given Prevnar instead of Pneumovax, accidentally given by fill in nurse helping that morning.
Pain in top of hands and pain in ankles. Taking Enbrel, still in pain. My work consists of heavy wrenching.
Patient received FLUZONE HIGH DOSE on 11/8/2018 in the afternoon. Went home and started stumbling in the middle of the night. Felt the same way when he woke up in the morning. Dizzy, disoriented, syncope.
Information has been received from a physician concerning a 4 month old patient who on approximately 30-Jun-2007 and August 2007 was vaccinated with the first and second oral dose of Rotateq. Concomitant vaccinations at 2 months of age included "other vaccines." In August 2007, the patient developed vomiting and bloody stools. Medical attention was sought via office visit and ER visit. The patient was then admitted to the hospital, where surgery was performed. The physician stated that "the intestine was not cut during the surgery but relaxed." Subsequently, the patient recovered. There was no product quality complaint. The events were also considered to be an other important medical event (surgery). Additional information has been requested.  10/02/2007 Vax record received from reporter and info updated in database.  10/03/2007 Additional vax records received from CDC.  Database updated. 10/30/2007 MR received for DOS 8/17-21/2007 for DX: Intussusception.  Child presented to ER with irritability, bilious vomiting and  bloody stool. Temp =101'F.  PE (+) for decreased BS and palpable mass.  Diagnostic and therapeutic Barium Enema attempted with findings compatible with IS.  Unsuccessful attempt at reduction x 3.   Taken to OR for Exploratory Lap, Reduction of small bowel Intussusception with appendectomy. 10/19/2007 Records received for subsequent ER visit of 9/9/007 for vomiting and irritability S/P Intussusception with Surgical reduction on 8/17/2007.  Infant vomited x3 at home.  Crying was similar to when pt had IS. Irritability improved in ER. DX: Non-infectious gastroenteritis and colitis.
Developed upper resp symptoms ~14 days ago w/ worsening gradually, prompting utc visit 1/22/22, at which time covid 19 pcr was +. Was prescribed z-pak and prednisone and patient thinks she got one dose of each. Today saw pcp in telemed follow up and sats were mid 80's and patient directed to go to ED where room air sats as low as 84%. cxr w/ faint suggestion of bilateral patchy infiltrates. Normal wbc count. Slightly elevated procalcitonin. Elevated crp. ekg shows afib rate 90's. Normal troponin, mildly elevated probnp. Some yellow sputum. Denies chest pain or palpitations, no orthopnea or LE edema. CT angio chest ordered by ED and hospitalist service requested to admit. Currently on 2Lnc sats mid 80's.
Vomiting, diarrhea, muscle weakness, severe joint pain, dizziness.
7 hours after the vaccine tiredness and mild nausea started.  Approximately 26 hours after the vaccination extreme dizziness occurred and he lost consciousness for a few  seconds.  He was clay and completely lost his coloring . His son is a retired HCP and we took vitals and within 30 minutes after drinking electrolytes he was back to normal.  We believe he was dehyrated. He has had vertigo in the past and has a pacemaker.  His blood pressure was taken in 3 positions and within less than 30 minutes after having him hydrate all symptoms subsided.  I emailed these symptoms to his Medical Doctor.  We also had him use his pacemaker monitoring system to send a report to his healthcare specialist.
Case number PHEH2012US018686 is an initial spontaneous report received from a health care professional on 05 Sep 2012: This report refers to an 11-year-old female child. Her medical history included of asthma. She was vaccinated with MENVEO (batch number: M11082 and expiry date: 31 May 2014) intramuscularly in right arm on 04 Sep 2012. Concomitantly she was also vaccinated with Hepatitis A vaccine (manufacturer: not reported, batch number: AHAVB646AA) and Tdap (other manufacturer, batch number: AC52B085BA) intramuscularly on 04 Sep 2012. It was reported that MENVEO vaccine had reached up to 11 degree Celsius for 30 to 60 minutes due to power outage. It was reported that vaccine was stable and was okay to administer. No adverse event was reported following this administration error (incorrect storage of drug). Follow up information received from the healthcare professional on 16 Oct 2012: Updated site of vaccination of MENVEO, concomitant vaccines administered and medical history.
Information has been received from a registered nurse concerning a 55 year old female patient with allergies to metaxalone (SKELAXIN) (hives) and erythromycin who on 07-NOV-2007 at approximately 15:30, was vaccinated IM into the right deltoid with a second 0.5ml dose of Pneumovax 23 (Lot#657626/1084U). On 09-NOV-2007, the patient presented to the physician's office complaining of a bad headache, achy, lethargic and cough for 48 hours. The patient was afebrile, had abdominal pain and decreased appetite, nausea but no vomiting or diarrhea and syncope. It was reported that the patient required admission to the hospital for cellulitis. At the time of this report, the patient's outcome was unknown. Additional information is not expected.
Inflammation and pain that progressed from upper body to lower body over 3-4 days. Upper body pain and inflammation subsided while the side effects moved to lower body extremities.
Information has been received from a health professional concerning a 68 year old female who on 24-OCT-2007 was vaccinated with a 0.65 mL dose in her left deltoid of zoster vaccine live (Oka/Merck) (Lot# 658208/0886U). Concomitant therapy included tramadol HC1, diazepam and statin (unspecified). On 26-OCT-2007, the patient began to experience deep burning and sting pain beneath the bra line of her left side. The patient was not experiencing a rash. It was noted that the patient called the office. At the time of the report the patient had not recovered. No other information was provided. No product quality complaint was involved. Additional information has been requested.
Started having terrible reactions to Black Fungus after second vaccine; Felt totally wiped out after the second vaccine; Some nights sleeps well and other nights  does not, after second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MUCORMYCOSIS (Started having terrible reactions to Black Fungus after second vaccine) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 06M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced POOR QUALITY SLEEP (Some nights sleeps well and other nights  does not, after second vaccine). On 13-Mar-2021, the patient experienced MUCORMYCOSIS (Started having terrible reactions to Black Fungus after second vaccine) (seriousness criterion medically significant) and FATIGUE (Felt totally wiped out after the second vaccine). At the time of the report, MUCORMYCOSIS (Started having terrible reactions to Black Fungus after second vaccine), POOR QUALITY SLEEP (Some nights sleeps well and other nights  does not, after second vaccine) and FATIGUE (Felt totally wiped out after the second vaccine) outcome was unknown.            The treatment history was not reported. The concomitant medication was not reported Patient stated that some nights he sleeps well and other nights he does not. The patient was wiped out. The blood work was done but no results provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I received a tingling sensation on my left arm immediately following the injection. Then over the next 24 hours I experienced soreness at the injection point, a headache, and fatigue. These symptoms went away and then about mid-next week (18 Aug 21) I started to experience chest tightening at rest and more intensely if I was walking or doing anything that was mildly physical. I Initially thought this was a panic attack (which was strange because I had never experienced a panic attack in my life). The chest tightening symptoms ebbed and flowed for about two weeks and eventually subsided. I also started to experienced black dots floating in my peripheral vision (these still have not gone away but appear sporadically). This was also strange because i never experienced this in my life.
Patient suffered from diffuse, warm rash spreading from the top of her left arm where the vaccine was given down to her elbow, with increased redness and bruising around the site of injection. She was said to feel fine outside of this ailment.
Left arm with area of erythema and warmth distal to injection site left upper arm - area approx. 4 cm long x 2 cm across.
He experienced some pain at the injection site and a headache for a couple days. He had exposure to COVID-19 from his teacher. He tested positive 01/08/2023 with a runny nose.  We contacted his pediatrician and the health department that he tested positive. He is not taking anything to help with his symptoms.
Information has been received from a Registered Pharmacist concerning an 80 year old female patient with no pertinent medical history and no drug reactions or allergies who on 21-SEP-2010 was vaccinated SQ with a dose of ZOSTAVAX (Merck) (Lot# 664670/0151Z). The pharmacist reported that the patient developed a site reaction after vaccination with ZOSTAVAX (Merck). The reaction began "yesterday" on 22-SEP-2010 with the injection site feeling warm and "puffy". "Today" on 23-SEP-2010, the patient's arm was swollen from the elbow to shoulder, red, hot and "puffy". The pharmacist recommended ice and BENADRYL. At the time of the report, the patient had not recovered. The patient sought medical attention by calling to the pharmacy. Follow-up has been received from a pharmacist who stated that on 21-SEP-2010 the patient was vaccinated SQ in the left arm with the first dose of ZOSTAVAX (Merck) (Lot# 664275/0960Y, reported previously as Lot# 664670/0151Z) at 13:30. The pharmacist reported that on 23-SEP-2010, the patient experienced redness, warmth and slight itchy sensation lasting at least a week. The patient did not seek medical attention. At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
tingling; This non-serious case was reported by a nurse via call center representative and described the occurrence of tingling in a 74-year-old female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, an unknown time after receiving Flu vaccine, the patient experienced tingling (Verbatim: tingling). The outcome of the tingling was unknown.   It was unknown if the reporter considered the tingling to be related to Flu vaccine.     It was unknown if the company considered the tingling to be related to Flu vaccine.  Additional Information: GSK Receipt Date: 11-OCT-2023 The nurse reported tingling following a flu vaccine 10 years ago (from the reporting date), thought it was the start of Guillain-Barre but did not develop into Guillain-Barre. The reporter was unsure of which flu vaccine was administered. The reporter consented to follow up.
9 hours post injection: fever.  20 hours post injection: chills, fever, body aches, malaise, headache.  Body aches lasted 36 hours. Fevers lasted 48 hours.  Headache lasted 120 hours.  Other symptoms lasted72 hours. Face still feels hot 5 days later.
Fever 100.2;  Extreme soreness at injection site;  Joint pain;  Confusion first night after injection (not thereafter)
Information has been received on 20-NOV-2017 from a lawyer and a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapy are unknown. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported), subcutaneous on or about 19-FEB-2014, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 19-OCT-2016, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster. The patient has been prescribed prednisone for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
22JUL97 lethargic, joint pain;23JUL97 sl fever;24JUL97 inc fever, chills;25JUL97 inc fever, chills;25JUL97 rash (small red bumps) on face, back, chest & stomach, few on legs;pt better 30JUL97;
Pt exhibiting stroke like symptoms with previous history of heart attack and a fib.  Presented to hospital and had heart and head scans - all clear but dehydrated. Once rehydrated, released and returned to work next day.
I start of feeling sick in the stomach, headache, muscle aches, feverish. By that night I had chills and the really bad nausea, that I had to sleep on the bathroom.  The next day, I barely made it to the bed. I am very weak, still having a headache, body aches and feeling fatigue. The ringing in my ear has gotten worst than it was before.
62 yof was admitted with left upper arm erythema and swelling. She received pneumonia vaccine and same evening developed fever, chills and blistering rash. She was started on IV Vancomycin and Cefepime. Patient was advised not to receive PNEUMOVAX vaccine in the future.
Lethargic, unable to stay awake, swollen lump at shot sites on thighs, feverish.
other zoster related injuries; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a patient (pt) of unknown age and gender. The pt's pertinent medical history, concurrent conditions or concomitant medications were not reported. On or about unknown date (reported as 40953), the pt was administered zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dosage, route of administration and anatomical location were not provided) for the long-term prevention of shingles and zoster-related conditions, by a healthcare provider. On an unknown date, subsequent to the pt's zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by a physician, nurse practitioner and other healthcare providers for shingles and other zoster related injuries. At the time of the report, the outcome of the events of shingles and other zoster-related injuries was unknown. The reporter considered both events to be related to zoster vaccine live (ZOSTAVAX).
Awakened scratching my sides and hips.  A red rash and red welts covered my shoulders, my torso, my back and hips. This seemed to localized on my right side, the side I was laying on.  The next day the rash was less prominent, less localized, some generalized itching. Two and a half days after the injection, the rash localized to points where my clothing was tight, groin, waist, and bra strap.  That was 9 PM on 9/22/13 and I took pictures at that time. The following morning the rash and itch were almost gone.  No further problem.
On routine CBC atypical lymphocytosis on 4APR92; 4APR92 10.3 12.1 35.0 381 p20/L60/B2/M7/E0/Bos2/at lymph 9; 8APR92 6.8 12.2 35 P29/L51/B4/M9/E1/at lymph 6; 27APR92 7.5 12.5 36.5 4.0 p24/l54/b2/M10/E6/Bos1/lymph 3;
Fever, 8 hours, post vax, of 101.3F and emesis X 1. On 6/30/01, had malaise and vomiting. On 7/1/01, was weak and quiet. On 7/2/01, tongue deviated to right side and drooling. Choking on saliva and poor tongue coordination with talking.
-Low grade fever- severe swelling (cellulitis with redness and itching) and cough.
Received a dose that was too small; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Received a dose that was too small) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Received a dose that was too small). At the time of the report, ACCIDENTAL UNDERDOSE (Received a dose that was too small) had resolved.            Treatment and concomitant medications were not provided by reporter.; Sender's Comments: This report refers to a case of Accidental Overdose for mRNA-1273 (Lot number: Unknown) with no associated AEs
After receiving the vaccine I felt extremely tired and worn out for 2 days. Then when I went to see my doctor to get a mammogram, that I get every 6 months, they told me I had breast cancer. I had surgery on Friday, May 13, 2022, and the lump is removed now. I will be starting radiation some time next month.
Chills, muscle aches,  no appetite, fever & very sore at injection site.  Lasted 6 hours.  Slept & took pain meds later.
I got my period a week early. It was heavy, painful, and had an unusual odor. My period usually last 4 days, this lasted 7.
Patient mistakenly received Td intradermally, instead of Tb skin test, and experienced red swelling at the injection site- 8mm, nausea, joint soreness, especially in a jaw and shoulder of arm with injection site. Follow up 02/06/2006. Patient is betting, swelling is subsiding, although still feels hard underneath. Patient noted that her jaws are fine now.
Information has been received from a physician concerning a 70 year old white female who on 10-MAY-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5 ml) (lot#651328/1046P), intramuscularly.  On 11-MAY-2006 the patient experienced deltoid area swelling, redness, throbbing pain, and chills. On 11-MAY-2006 her arm felt better.  On 12-MAY-2006 the patient recovered.  Additional information has been requested.
covid vaccine breakthrough case  dose 1 Pfizer  3/30/21  ER2613 dose 2 Pfizer  4/20/21  EW0150
Patient had #3 Anthrax on 5/24/04 in left arm SC at 10:00. Patient stated on 5/25/04 at approximately 19:00, left arm got very red, hot, swollen with shooting pain down to hand. This continued for approximately 1 hour. Patient called MD on call; was told to go the ER> Patient went to ER and was told to use ice packs 20 minutes every 4 hours while awake. Placed on Benadryl 25mg PO every 4-6 hours and Motrin 800mg every 8 hours for 72 hours. Called patient today and she says she's feeling better and less swelling, less pain and less erythema.
This spontaneous report was received from a certified medical assistant, referring to an unspecified number of patients of unknown ages and genders, who had human immunodeficiency virus (HIV). It was reported that the patients were being vaccinated with PNEUMOVAX 23 "every five years" (dose, route, lot # and expiration date were not reported). The reporter stated it was not possible to know how many total doses of the PNEUMOVAX 23 each patient received. No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
At day 8 after vaccinations, had 3 to 4 day illness with fever up to 102.8, blanching erythematous rash on torso and face, decreased appetite and fussiness, crying as if in pain
Patient felt itchy. No rash noted, she didn't seem to be in distress. Vitals were taken, nurse reported elevated blood pressure, but didn't say how high. Reported doesn't have that information. Patient was walked to the hospitals ER. Reporter states patient wasn't admitted.
Child rec'd KINRIX vaccine as booster for DTAP/Polio series and he is < 4 yrs of age. Vaccines were #4 DTAP and #3 IPV. Mom notified, No concerns or c/o.
Swollen innoculation site (about 4" diameter of discoloration and soreness). Chills (uncontrollable shivering) approximately 9 hours after the innoculation and lasting 18 hours. Fever and malaise keeping the patient in bed 3 full nights and days following the innoculation. (All adverse reactions from pneumonia shot.)
pt recv vax 27OCT97 & 25DEC98 devel fever & did not feel well;
Developed fever about 7 days after vaccine. Fever resolved, then developed weakness, pain, inability to walk, numbness in feet about 3 wks after vaccine. Admitted to hospital. Diagnosed w/Guillain Barre Syndrome. Now in the ICU on a ventilator, has a trach. Still unable to walk. Has been in hospital now for seven weeks.